Inhibitory Effect of Thymoquinone on Testosterone-Induced Benign Prostatic Hyperplasia in Wistar Rats
Author:
Affiliation:
1. Department of Biological Sciences; Yarmouk University; Irbid Jordan
2. Department of Basic Medical Sciences, Faculty of Medicine; Yarmouk University; Irbid Jordan
3. Faculty of Pharmacy; Yarmouk University; Irbid Jordan
Funder
Deanship of Research and Graduate Studies at Yarmouk University
Publisher
Wiley
Subject
Pharmacology
Reference34 articles.
1. The effect of route of administration in thymoquinone toxicity in male and female rats;AbuKhader;Indian J Pharm Sci,2012
2. Oral and intraperitoneal LD50 of thymoquinone, an active principle of Nigella sativa, in mice and rats;Al-Ali;J Ayub Med Coll Abbottabad,2008
3. Effects of flavocoxid, a dual inhibitor of COX and 5-lipoxygenase enzymes, on benign prostatic hyperplasia;Altavilla;Br J Pharmacol,2012
4. Anti-angiogenic activity of thymoquinone by the down-regulation of VEGF using zebrafish (Danio rerio) model;Arumugam;Biomed Prev Nutr,2012
5. Thymoquinone suppresses cellular proliferation, inhibits VEGF production and obstructs tumor progression and invasion in the rat model of DMH-induced colon carcinogenesis;Asfour;Pharmacology & Pharmacy,2013
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Chemopreventive Efficacy of Thymoquinone in Chemically Induced Urinary Bladder Carcinogenesis in Rat;BioMed Research International;2022-09-15
2. Photothermal therapeutic potency of plasmonic silver nanoparticles for apoptosis and anti-angiogenesis in testosterone induced benign prostate hyperplasia in rats;Life Sciences;2022-02
3. Chemical profiles of the active fraction from Prinsepia utilis Royle leaves and its anti-benign prostatic hyperplasia evaluation in animal models;BMC Complementary Medicine and Therapies;2021-10-29
4. Thymoquinone, as a Novel Therapeutic Candidate of Cancers;Pharmaceuticals;2021-04-16
5. Meet Our Editorial Board Member;Pharmaceutical Nanotechnology;2021-03-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3